RMD and CSL Limited: 2 ASX shares for your watchlist
Rask Invest Research Team
November 16, 2023
The Resmed CDI (ASX:RMD) share price has decreased 23.3% since
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The Resmed CDI (ASX:RMD) share price has decreased 23.3% since
The CSL Limited (ASX:CSL) share price is down around 10.0%
The Washington H Sl Pttnsn nd Cmpny Ltd (ASX:SOL) share
The benchmark S&P/ASX 200 (INDEXASX: XJO) index advanced 19.5 points,
The S&P/ASX 200 (INDEXASX: XJO) closed 19.2 points, or 0.3%,
The Australian share market staged a strong rally to begin
This episode gives you an overview of the 10 LARGEST
The benchmark S&P/ASX 200 (INDEXASX: XJO) closed 2.6 points lower,
The benchmark S&P/ASX 200 (INDEXASX: XJO) index added 12.8 points,
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
